{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T10:00:47Z","timestamp":1648980047703},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1007\/bf02966394","type":"journal-article","created":{"date-parts":[[2008,10,9]],"date-time":"2008-10-09T13:44:56Z","timestamp":1223559896000},"page":"302-306","source":"Crossref","is-referenced-by-count":0,"title":["High dose chemotherapy as adjuvant treatment in operable Breast Cancer with 10 or more involved axillary lymph nodes"],"prefix":"10.1007","volume":"7","author":[{"given":"Eiichi","family":"Shiba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Akazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumine","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyasu","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinzaburo","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02966394_CR1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1200\/JCO.1985.3.2.259","volume":"3","author":"G Bonadonna","year":"1985","unstructured":"Bonadonna G, Valagusssa P: Adjuvant systemic therapy for resectable breast cancer.J Clin Oncol 3:259\u2013275, 1985.","journal-title":"J Clin Oncol"},{"key":"BF02966394_CR2","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1200\/JCO.1993.11.6.1132","volume":"11","author":"WP Peters","year":"1993","unstructured":"Peters WP, Ross M, Vredenburg JJ,et al: High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant chemotherapy for high-risk breast cancer.J Clin Oncol 11:1132\u20131143, 1993.","journal-title":"J Clin Oncol"},{"key":"BF02966394_CR3","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1200\/JCO.1997.15.5.1870","volume":"15","author":"KH Antman","year":"1997","unstructured":"Antman KH, Rowlings PA, Vaughan WPet al: high-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.J Clin Oncol 15:1870\u20131879, 1997.","journal-title":"J Clin Oncol"},{"key":"BF02966394_CR4","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1200\/JCO.1997.15.8.2882","volume":"15","author":"G Solomo","year":"1997","unstructured":"Solomo G, Doroshow JH, Forman SJ,et al: high-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: Prognostic indicators of progression-free and overall survival.J Clin Oncol 15:2882\u20132893, 1997.","journal-title":"J Clin Oncol"},{"key":"BF02966394_CR5","first-page":"109A","volume":"16","author":"M DeLima","year":"1997","unstructured":"DeLima M, Mehra R, van Besien K,et al: high-dose chemotherapy (HDCT) and autologous blood and marrow transplant (BMT) for high-risk beast cancer (BC) [abstract]Proc ASCO 16:109A:A383, 1997.","journal-title":"Proc ASCO"},{"key":"BF02966394_CR6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00000421-199810000-00022","volume":"21","author":"LS Schwartz","year":"1998","unstructured":"Schwartz LS, Birch R, West WH,et al: Sequential treatment including high-risk stage II-III breast cancer: Outpatient administration in community cancer centers.Am J Clin Oncol 21:523\u2013531, 1998.","journal-title":"Am J Clin Oncol"},{"key":"BF02966394_CR7","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1200\/JCO.1997.15.6.2312","volume":"15","author":"AM Gianni","year":"1997","unstructured":"Gianni AM, Siena S, Bregni M,et al: Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: Five-year results.J Clin Oncol 15:2312\u20132321, 1997","journal-title":"J Clin Oncol"},{"key":"BF02966394_CR8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0140-6736(98)01350-6","volume":"352","author":"S Rodenuis","year":"1998","unstructured":"Rodenuis S, Richel D, Van der Wall E,et al: Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement.Lancet 352:515\u2013521, 1998.","journal-title":"Lancet"},{"key":"BF02966394_CR9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/jnci\/92.3.225","volume":"92","author":"GN Hortobagyi","year":"2000","unstructured":"Hortobagyi GN, Buzdar AU, Theriault RL,et al: Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.J Natl Cancer Inst 92:225\u2013233, 2000.","journal-title":"J Natl Cancer Inst"},{"key":"BF02966394_CR10","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0277-5379(89)90382-9","volume":"25","author":"AM Gianni","year":"1989","unstructured":"Gianni AM, Bonadonna G: High dose chem-radio-therapy for sensitive tumors: Is sequential better than concurrent drug delivery?Eur J Cancer Clin Oncol 25:1027\u20131030, 1989.","journal-title":"Eur J Cancer Clin Oncol"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02966394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02966394\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02966394","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T21:14:56Z","timestamp":1558473296000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02966394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["BF02966394"],"URL":"https:\/\/doi.org\/10.1007\/bf02966394","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}